Design, synthesis and biological activity of cell-penetrating peptide-modified octreotide analogs

Journal of Peptide Science

Volumn 16, Issue 2, 2010, Pages 105-109

  Xie, Wenlin ^a,b,c   Liu, Jian ^c   Qiu, Minghua ^a   Yuan, Jiancheng ^c   Xu, Anlong ^b  

^a HUNAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Shenzhen Kangzhe Pharmaceutical Co Ltd   (China)

Author keywords

Anticancer activity; Cell penetrating peptide; Octreotide; Peptide synthesis

Indexed keywords

ANTINEOPLASTIC AGENT; CELL PENETRATING PEPTIDE; CMTPT 01; CMTPT 02; CMTPT 03; CMTPT 04; OCTREOTIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SOLID PHASE SYNTHESIS;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DESIGN; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; OCTREOTIDE; STOMACH NEOPLASMS;

EID: 74749103327     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1205     Document Type: Article

References (35)

1. Guillemin R. Peptides in the brain: the new endocrinology of the neuron. Science 1978; 202: 390-402.
2. Reichlin S. Somatostatin (part 1). N. Engl. J. Med. 1983; 309: 1495-1501.
3. Reichlin S. Somatostatin (part 2). N. Engl. J. Med. 1983; 309: 1556-1563.
4. Reubi JC, Kvols LK, Krenning EP, Lamberts SWJ. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990; 39: (Suppl. 2): 78-81.
5. Reubi JC, LangW, Maurer R, Koper WJ, Lamberts SWJ. Distribution and biochemical characterization of somatostatin receptors in tumors of the central nervous system. Cancer Res. 1987; 47: 5758-5764.
6. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of cancer. Endocrine Rev. 1991; 19: 450-482.
7. Scambia G, Panici PB, Baiocchi G, Perrone L, Iacobelli S, Mancuso S. Antiproliferativeeffects of somatostatinandthesomatostatinanalog SMS 201-995 on three human breast cancer cell lines. J. Cancer Res. Clin. Oncol. 1988; 114: 306-308.
8. Andersson P, Forssell-Aronsson E, Johanson V, Wangberg B, Nilsson O, Fjalling M, Ahlman H. Internalization of Indium-111 into human neuroendocrine tumor cells after incubation with Indium-111-DTPA-D-Phe-Octreotide. J. Nucl.Med. 1996; 37: 2002-2006.
9. BauerW, Briner U, DoepfnerW, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 1982; 31: 1133-1140.
10. Lamberts SJ, Krenning EP, Klijn JGM, Reubi JC. The clinical use of somatostatin analogues in the treatment of cancer. Bailliere's Clin. Endocrinol. Metab. 1990; 4: 29-49.
11. Gewirtz AM, Sokol DL, Ratajczak MZ. Nucleic acid therapeutics: state of the art and future prospects. Blood 1998; 92: 712-736.
12. Juliano RL, Alahari S, Yoo H, Kole R, Cho M. Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides. Pharm. Res.(NY) 1999; 16: 494-502.
13. Stevenson CL. Advances in peptide pharmaceuticals. Curr. Pharm. Biotech. 2009; 10: 122-137.
14. Lundberg P, Langel U. A brief introduction to cell-penetrating peptides. J.Mol. Recognit. 2003; 16: 227-233.
15. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B. Cell-penetrating peptides. J. Bio. Chem. 2003; 278: 585-590.
16. Derossi D, Joliot AH, Chassaing G, Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994; 269: 10444-10450.
17. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 1997; 272: 16010-16017.
18. Lindgren M, Hallbrink M, Prochiantz A, Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 2000; 21: 99-103.
19. Schwarze SR, Hruska KA, Dowdy SF. Protein transduction: unrestricted delivery into all cells? Trends Cell Biol. 2000; 10: 290-295.
20. Shibagaki N, Udey MC. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J. Immunol. 2002; 168: 2393-2401.
21. Pooga M, Soomets U, Hallbrink M, Valkna A, Saar K, Rezaei K, Kahl U, Hao JX, Xu XJ,Wiesenfeld-Hallin Z, Hokfelt T, Bartfai T, Langel U. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 1998; 16: 857-861.
22. Astriab-Fischer A, Sergueev D, FischerM, Shaw BR, Juliano RL. Conjugates of antisense oligonucleotides with the Tat and Antennapedia Cell-Penetrating peptides : effects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res.(NY) 2002; 19: 744-754.
23. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci.U. S.A. 1994; 91: 664-668.
24. Nagahara H, Vocero-Akbani AM, Snyder EL, Latham DG, Lissy NA, Becker-Hapak M,Ezhevsky SA,Dowdy SF.Transductionof full-length TAT fusion proteins into mammalian cells : TAT-p27 induces cell migration. Nat. Med. 1998; 4: 1449-1452.
25. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999; 285: 1569-1572.
26. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tatpeptide-derivatizedmagnetic nanoparticales allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 2000; 18: 410-414.
27. Torchilin VP, Rammohan R,Weissig V, Levchenko TS. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 8786-8791.
28. Kuroda M, Mimaki Y, Sashida Y, Hirano T, Oka K, Dobashi A, Li H, Harada N. Novel cholestane glycosides from the bulbs of Ornithogalum saundersiae and their cytostatic activity on leukemia HL-60 and MOLT-4 cells. Tetrahedron 1997; 53: 11549-11562.
29. Rodriguez M, Llinares M, Doulut S, Heitz A, Martinez J. A facile synthesis of chiral N-protected α-amino alcohols. Tetrahedron Lett. 1991; 32: 923-926.
30. Yasushi A, Hiromichi A, Takashi U, Kenichi A, Masahiro O. Conventional and high-yield synthesis of DTPA-conjugated peptides: application of a monoreactive DTPA to DTPA-D-Phe1-octreotide synthesis. Bioconjugate Chem. 1997; 8: 442-446.
31. Wang SS, Gisin BF, Winter DP, Makofske R, Kulesha ID, Tzougraki C, Meienhofer J. Facile synthesis of amino acid and peptide esters under mild conditions via cesium salts. J. Org. Chem. 1977; 42: 1286-1290.
32. Kaiser E, Colescott R, Bossinger CD, Cook P. Color test for detection of free amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 1970; 34: 595-598.
33. Ellman G. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959; 82: 70-77.
34. BauerW, BrinerU, DoepfnerW, HalierR, HugueninR, MarbachP, Petcher TJ, Pless J. SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Live Sci. 1982; 31: 1133-1140.
35. Wynants C, Van Binst G, Loosli HR. Hexapeptide analogue of somatostatin, Sandoz 201-456. Conformational study in dimethylsulfoxide by 1 D and 2D n.m.r. methods. Int. J. Peptide Protein Res. 1985; 25: 622-627.